Becton Dickinson & Co (NYSE:BDX)
$ 235.67 0.67 (0.29%) Market Cap: 68.11 Bil Enterprise Value: 82.95 Bil PE Ratio: 51.91 PB Ratio: 2.65 GF Score: 80/100

Becton Dickinson and Co at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 09, 2020 / 05:20PM GMT
Release Date Price: $231.33 (-4.03%)
Amit Hazan;Thomas
Goldman Sachs Group, Inc., Research Division - Equity Analyst

All right. Good afternoon. We're getting ready here in day 1 to start the afternoon sessions. And this is med tech again. My name is Amit Hazan. I'm the medical technology analyst at Goldman. From my team, you have, as always, Jamie Perse and Phil Coover with me. And the next presenting company will be Becton, Dickinson. And before I introduce them, I just wanted to remind folks that we've got a survey out there. As we've gone in years past, we've got a very quick survey just being hosted on the conference page and in your e-mail inbox and who have the live polling, and we would be grateful to get your feedback and really appreciate your participation this year.

All right. So with that, we have Becton, Dickinson as our next presenters. We've got both Tom Polen, the Chief Executive Officer; and Chris Reidy, the Chief Financial Officer. And first and foremost, both of you -- we're really thankful that you can join. We know it's an extremely busy time. So thanks for making the time for us, and welcome.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot